Skip to main content

Security report for msd.hu

Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside US and Canada) · Healthcare · Hungary

Low risk. 3 critical or high findings in GDPR outside view and SSL/TLS.

Security score

76/100

Risk levelLow

0–100, higher is better. How it is calculated

MSD Hungary is a large, well-established pharmaceutical company operating under the global Merck & Co., Inc. brand. The company focuses on innovative therapies, vaccines, and clinical research to improve patient health and quality of life. Their website reflects a mature digital presence with professional design, clear navigation, and comprehensive content targeted at patients, healthcare professionals, and partners. Technically, the site is built on WordPress with modern SEO and privacy compliance tools such as Yoast SEO and OneTrust for cookie consent. Security posture is good with HTTPS enforced and no visible vulnerabilities, though some security headers could be improved. Overall, the domain age and WHOIS data align with the company's claims, supporting legitimacy and trustworthiness.

Scanned

NIS2 and GDPR posture

GDPR outside view
80/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048

Need hands-on remediation? Email guard@offseq.com

Keep watching msd.hu

This scan found 19 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
42
Security headers
80
Email security
70
DNS health
85
Network security
100
GDPR outside view
80
Average
76

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

MSD Hungary holds a strong market position as a subsidiary of a global pharmaceutical leader. Their business model centers on research, development, and distribution of medicines and vaccines, supported by strategic collaborations and clinical trials. The company targets healthcare providers, patients, and researchers, emphasizing innovation and patient outcomes. Their partnership ecosystem includes subsidiaries focused on animal health and maternal health. The website's multilingual and regional links indicate a broad international footprint. Growth indicators include active clinical research and strategic university collaborations.

Security posture

The website demonstrates a solid security foundation with HTTPS and cookie consent mechanisms in place. No exposed sensitive data or vulnerable libraries were detected. However, the absence of explicit security headers like Content-Security-Policy and X-Frame-Options suggests room for enhancement. Incident response and security policy information are not publicly available, which could be improved to increase transparency and readiness. Overall, the security maturity is good but could benefit from additional hardening and documented policies.

Recommendations

  1. Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
  2. Publish a clear security policy and incident response contact information on the website.
  3. Regularly audit and update third-party scripts and WordPress plugins to mitigate vulnerabilities.
  4. Enhance form security with anti-CSRF tokens and input validation.
  5. Maintain and communicate data retention and privacy policies clearly to users.

Contact details published on the site

Addresses
Legal name
MSD Pharma Hungary Kft.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside US and Canada)
Description
MSD Hungary is committed to improving patient health and quality of life through innovative therapies and pioneering research, focusing on prevention and curative care, with strategic collaborations in clinical research.
Key services
Pharmaceutical products, Vaccines, Clinical trials, Research and development
Content quality
excellent
Branding
consistent

Technology

Stack
WordPress, Yoast SEO plugin, Tiny Slider (tns), Google Tag Manager, OneTrust Cookie Consent, LazyLoad images
Frameworks
WordPress
Platforms
WordPress CMS
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data in HTML
  • Use of Google Tag Manager for controlled script loading

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. Strong compliance with GDPR and cookie consent regulations.
  3. Professional healthcare industry website with clear business focus.
  4. Use of modern web technologies and SEO best practices.
  5. Presence of multiple language and regional MSD sites linked.
  6. Contact information is clearly provided with multiple channels.
  7. No suspicious or malicious content detected.
Technical notes

Notes

The website uses WordPress CMS with Yoast SEO for optimization and OneTrust for cookie consent management, indicating a modern and privacy-aware infrastructure. Google Tag Manager is used for analytics and marketing scripts, allowing controlled script deployment. The site employs lazy loading for images and responsive design techniques, ensuring good performance and mobile usability. While hosting details are not explicit, the site loads efficiently with moderate performance. Technical debt appears low, but security header implementation and incident response readiness could be improved to reduce risk.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with msd.hu. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review msd.hu.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.